Mallik Greene

The economic burden of bipolar I disorder in the United States in 2015

Martin Cloutier, Mallik Greene, Annie Guérin et al. · Journal of Affective Disorders · 2017 · 208 citations · Full text

Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder

Mallik Greene, Tingjian Yan, Eunice Chang et al. · Journal of Medical Economics · 2017 · 188 citations

The impact on functioning of second-generation antipsychotic medication side effects for patients with schizophrenia: a worldwide, cross-sectional, web-based survey

Rajiv Tandon, William R. Lenderking, Catherine Weiss et al. · Annals of General Psychiatry · 2020 · 65 citations · Full text

Medication Adherence and Discontinuation of Aripiprazole Once-Monthly 400 mg (AOM 400) Versus Oral Antipsychotics in Patients with Schizophrenia or Bipolar I Disorder: A Real-World Study Using US Claims Data

Tingjian Yan, Mallik Greene, Eunice Chang et al. · Advances in Therapy · 2018 · 46 citations · Full text

Early initiation of long-acting injectable antipsychotic treatment is associated with lower hospitalization rates and healthcare costs in patients with schizophrenia: real-world evidence from US claims data

Jennifer Munday, Mallik Greene, Eunice Chang et al. · Current Medical Research and Opinion · 2019 · 33 citations